Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivlty of naphthalene epoxidation

Gwyn Pakenham, Jozsef Lango, Michael Buonarati, Dexter Morin, Alan R Buckpitt

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Previous work has shown that the rate and stereochemistry of naphthalene epoxidation correlates with differences in susceptibility to cytotoxicity. The development of methods for measuring epoxide formation in vivo could provide a marker for assessing events critical to naphthalene cytotoxicity that are applicable to humans. Here, urinary diastereomeric mercapturates have been measured in mice (susceptible) and rats (nonsusceptible) after intraperitoneal administration (1.56-200 mg/kg) or inhalation exposures (0.8-110 ppm, 4 h) to naphthalene. No significant differences were observed in the percentage of the dose eliminated as mercapturate in urine between mice (25-34%) and rats (24-35%) or at varying doses after i.p. administration. The amounts of urinary mercapturate after 4-h exposures were considerably greater in mice than rats. In mice, the ratio of diastereomeric mercapturates derived from the 1R,2S- to 1S,2R-epoxide was 1:1 at Iow doses (1-3 mg/kg), increased to 3:1 at intermediate doses (50 mg/kg), and decreased to 2-1 at high doses (100 and 200 mg/kg). In rats, these ratios remained less than 1:1 at all doses. After inhalation, ratios were 5 to 6:1 at low concentrations (less than 15 ppm) and decreased to 3.1 at higher concentrations (15-100 ppm) in mice, whereas in rats, the ratios were 1:1 or less for all concentrations. These studies show that mercapturates provide good assessments of internal dose, that there are not significant differences between mice and rats in the percentage eliminated as mercapturate but that the ratios of mercapturates derived from the 1R,2S-versus 1S,2R-epoxide differ markedly and are consistent with previous in vitro metabolism studies.

Original languageEnglish (US)
Pages (from-to)247-253
Number of pages7
JournalDrug Metabolism and Disposition
Volume30
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Epoxidation
Biomarkers
Rats
Epoxy Compounds
Cytotoxicity
Inhalation Exposure
Stereochemistry
Metabolism
Inhalation
naphthalene
Urine

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivlty of naphthalene epoxidation. / Pakenham, Gwyn; Lango, Jozsef; Buonarati, Michael; Morin, Dexter; Buckpitt, Alan R.

In: Drug Metabolism and Disposition, Vol. 30, No. 3, 2002, p. 247-253.

Research output: Contribution to journalArticle

Pakenham, Gwyn ; Lango, Jozsef ; Buonarati, Michael ; Morin, Dexter ; Buckpitt, Alan R. / Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivlty of naphthalene epoxidation. In: Drug Metabolism and Disposition. 2002 ; Vol. 30, No. 3. pp. 247-253.
@article{faf72edc06a045f4a9590ad99bec8f9c,
title = "Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivlty of naphthalene epoxidation",
abstract = "Previous work has shown that the rate and stereochemistry of naphthalene epoxidation correlates with differences in susceptibility to cytotoxicity. The development of methods for measuring epoxide formation in vivo could provide a marker for assessing events critical to naphthalene cytotoxicity that are applicable to humans. Here, urinary diastereomeric mercapturates have been measured in mice (susceptible) and rats (nonsusceptible) after intraperitoneal administration (1.56-200 mg/kg) or inhalation exposures (0.8-110 ppm, 4 h) to naphthalene. No significant differences were observed in the percentage of the dose eliminated as mercapturate in urine between mice (25-34{\%}) and rats (24-35{\%}) or at varying doses after i.p. administration. The amounts of urinary mercapturate after 4-h exposures were considerably greater in mice than rats. In mice, the ratio of diastereomeric mercapturates derived from the 1R,2S- to 1S,2R-epoxide was 1:1 at Iow doses (1-3 mg/kg), increased to 3:1 at intermediate doses (50 mg/kg), and decreased to 2-1 at high doses (100 and 200 mg/kg). In rats, these ratios remained less than 1:1 at all doses. After inhalation, ratios were 5 to 6:1 at low concentrations (less than 15 ppm) and decreased to 3.1 at higher concentrations (15-100 ppm) in mice, whereas in rats, the ratios were 1:1 or less for all concentrations. These studies show that mercapturates provide good assessments of internal dose, that there are not significant differences between mice and rats in the percentage eliminated as mercapturate but that the ratios of mercapturates derived from the 1R,2S-versus 1S,2R-epoxide differ markedly and are consistent with previous in vitro metabolism studies.",
author = "Gwyn Pakenham and Jozsef Lango and Michael Buonarati and Dexter Morin and Buckpitt, {Alan R}",
year = "2002",
doi = "10.1124/dmd.30.3.247",
language = "English (US)",
volume = "30",
pages = "247--253",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Urinary naphthalene mercapturates as biomarkers of exposure and stereoselectivlty of naphthalene epoxidation

AU - Pakenham, Gwyn

AU - Lango, Jozsef

AU - Buonarati, Michael

AU - Morin, Dexter

AU - Buckpitt, Alan R

PY - 2002

Y1 - 2002

N2 - Previous work has shown that the rate and stereochemistry of naphthalene epoxidation correlates with differences in susceptibility to cytotoxicity. The development of methods for measuring epoxide formation in vivo could provide a marker for assessing events critical to naphthalene cytotoxicity that are applicable to humans. Here, urinary diastereomeric mercapturates have been measured in mice (susceptible) and rats (nonsusceptible) after intraperitoneal administration (1.56-200 mg/kg) or inhalation exposures (0.8-110 ppm, 4 h) to naphthalene. No significant differences were observed in the percentage of the dose eliminated as mercapturate in urine between mice (25-34%) and rats (24-35%) or at varying doses after i.p. administration. The amounts of urinary mercapturate after 4-h exposures were considerably greater in mice than rats. In mice, the ratio of diastereomeric mercapturates derived from the 1R,2S- to 1S,2R-epoxide was 1:1 at Iow doses (1-3 mg/kg), increased to 3:1 at intermediate doses (50 mg/kg), and decreased to 2-1 at high doses (100 and 200 mg/kg). In rats, these ratios remained less than 1:1 at all doses. After inhalation, ratios were 5 to 6:1 at low concentrations (less than 15 ppm) and decreased to 3.1 at higher concentrations (15-100 ppm) in mice, whereas in rats, the ratios were 1:1 or less for all concentrations. These studies show that mercapturates provide good assessments of internal dose, that there are not significant differences between mice and rats in the percentage eliminated as mercapturate but that the ratios of mercapturates derived from the 1R,2S-versus 1S,2R-epoxide differ markedly and are consistent with previous in vitro metabolism studies.

AB - Previous work has shown that the rate and stereochemistry of naphthalene epoxidation correlates with differences in susceptibility to cytotoxicity. The development of methods for measuring epoxide formation in vivo could provide a marker for assessing events critical to naphthalene cytotoxicity that are applicable to humans. Here, urinary diastereomeric mercapturates have been measured in mice (susceptible) and rats (nonsusceptible) after intraperitoneal administration (1.56-200 mg/kg) or inhalation exposures (0.8-110 ppm, 4 h) to naphthalene. No significant differences were observed in the percentage of the dose eliminated as mercapturate in urine between mice (25-34%) and rats (24-35%) or at varying doses after i.p. administration. The amounts of urinary mercapturate after 4-h exposures were considerably greater in mice than rats. In mice, the ratio of diastereomeric mercapturates derived from the 1R,2S- to 1S,2R-epoxide was 1:1 at Iow doses (1-3 mg/kg), increased to 3:1 at intermediate doses (50 mg/kg), and decreased to 2-1 at high doses (100 and 200 mg/kg). In rats, these ratios remained less than 1:1 at all doses. After inhalation, ratios were 5 to 6:1 at low concentrations (less than 15 ppm) and decreased to 3.1 at higher concentrations (15-100 ppm) in mice, whereas in rats, the ratios were 1:1 or less for all concentrations. These studies show that mercapturates provide good assessments of internal dose, that there are not significant differences between mice and rats in the percentage eliminated as mercapturate but that the ratios of mercapturates derived from the 1R,2S-versus 1S,2R-epoxide differ markedly and are consistent with previous in vitro metabolism studies.

UR - http://www.scopus.com/inward/record.url?scp=0036183434&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036183434&partnerID=8YFLogxK

U2 - 10.1124/dmd.30.3.247

DO - 10.1124/dmd.30.3.247

M3 - Article

VL - 30

SP - 247

EP - 253

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 3

ER -